Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 114,754 | Dec 19, 2023, 03:55 PM | |
RCEL | AVITA Medical, Inc. | PERRY MICHAEL S | Director | Nov 21, 2022 | Sale | $6.58 | 300,000 | 1,975,500 | 379,543 | Nov 22, 2022, 04:46 PM | |
RCEL | AVITA Medical, Inc. | PERRY MICHAEL S | Chief Executive Officer | Feb 24, 2022 | Sale | $8.74 | 10,812 | 94,497 | 321,712 | Feb 25, 2022, 04:54 PM | |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Director | Jan 03, 2022 | Sale | $64.71 | 4,500 | 291,192 | 87,372 | Jan 04, 2022, 09:30 PM | |
RCEL | AVITA Medical, Inc. | PERRY MICHAEL S | Chief Executive Officer | Sep 01, 2021 | Sale | $20.68 | 11,220 | 232,030 | 237,638 | Sep 07, 2021, 04:05 PM | |
RCEL | AVITA Medical, Inc. | PERRY MICHAEL S | Chief Executive Officer | Jun 02, 2021 | Sale | $17.33 | 23,000 | 398,590 | 225,104 | Jun 04, 2021, 04:06 PM | |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Director | Jan 04, 2021 | Sale | $76.09 | 4,000 | 304,360 | 90,000 | Jan 05, 2021, 06:14 PM | |
RCEL | Avita Therapeutics, Inc. | PERRY MICHAEL S | Chief Executive Officer | Sep 14, 2020 | Sale | $26.99 | 15,092 | 407,333 | 457,856 | Sep 16, 2020, 07:15 PM | |
RCEL | Avita Therapeutics, Inc. | PERRY MICHAEL S | Chief Executive Officer | Sep 15, 2020 | Sale | $27.23 | 23,769 | 647,230 | 434,087 | Sep 16, 2020, 07:15 PM | |
RCEL | Avita Therapeutics, Inc. | PERRY MICHAEL S | Chief Executive Officer | Sep 16, 2020 | Sale | $27.41 | 9,000 | 246,690 | 425,087 | Sep 16, 2020, 07:15 PM | |
RCEL | Avita Therapeutics, Inc. | PERRY MICHAEL S | Chief Executive Officer | Sep 10, 2020 | Sale | $26.26 | 7,128 | 187,181 | 424,444 | Sep 11, 2020, 07:59 PM | |
RCEL | Avita Therapeutics, Inc. | PERRY MICHAEL S | Chief Executive Officer | Sep 11, 2020 | Sale | $26.02 | 20,000 | 520,400 | 404,444 | Sep 11, 2020, 07:59 PM | |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Director | May 14, 2020 | Option Exercise | $3.70 | 77,000 | 285,200 | 85,000 | May 18, 2020, 06:27 PM | |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Director | May 12, 2020 | Sale | $35.83 | 36,000 | 1,289,891 | 14,100 | May 13, 2020, 06:48 PM | |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Director | Sep 11, 2019 | Sale | $30.00 | 85,000 | 2,550,000 | 36,000 | Sep 11, 2019, 08:09 PM | |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Director | Sep 09, 2019 | Sale | $28.90 | 100,000 | 2,890,000 | 121,000 | Sep 11, 2019, 08:09 PM | |
APHB | AmpliPhi Biosciences Corp | PERRY MICHAEL S | Director | Mar 22, 2018 | Buy | $1.10 | 181,820 | 200,002 | 411,105 | Mar 26, 2018, 08:51 PM | |
PARD | PONIARD PHARMACEUTICALS, INC. | PERRY MICHAEL S | President & CMO | Mar 27, 2012 | Sale | $0.83 | 1,599 | 1,330 | 8,920 | Mar 27, 2012, 07:05 PM | |
PARD | PONIARD PHARMACEUTICALS, INC. | PERRY MICHAEL S | President & CMO | Feb 16, 2012 | Sale | $0.87 | 6,346 | 5,508 | 7,719 | Feb 17, 2012, 06:23 PM | |
PARD | PONIARD PHARMACEUTICALS, INC. | PERRY MICHAEL S | President & CMO | Apr 13, 2011 | Sale | $0.37 | 45,140 | 16,864 | 81,860 | Apr 14, 2011, 05:16 PM |